Apellis’ Empaveli Data In Frontline PNH Incremental, But Still Helpful

Data Could Aid Uptake Despite Already Broad Label

Render illustration of Clinical Trial title on medical documents
Results of Apellis' PRINCE study of Empaveli seen as having incremental benefit for already-approved drug • Source: Shutterstock

More from Blood and Clotting

More from Therapeutic Category